-
MMJ BioPharma Cultivation To Produce Quality Cannabis, Meeting DEA's Definition Of Chemical Reproducibility
Tuesday, April 26, 2022 - 9:15pm | 614MMJ BioPharma Cultivation, a cannabis company, received its DEA schedule 1 Analytical Lab Registration, which allows for the international importation of cannabis for research and development. In addition, MMJ BioPharma has been awarded FDA “Orphan Designation” for its clinical trial in...